argenx SE (ARGX)
963.37
-17.96
(-1.83%)
USD |
NASDAQ |
Nov 13, 10:06
argenx Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -19.76M |
| Cellectis SA | -14.59M |
| Halozyme Therapeutics, Inc. | 255.22M |
| DBV Technologies SA | -53.67M |
| Akari Therapeutics Plc | -3.112M |